Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 6 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Tricida, Inc. | 6,577,189 | reported | 16 Jun 2022 | tx 1+5,951 |
| KalVista Pharmaceuticals, Inc. | 5,278,985 | reported | 13 Feb 2025 | tx 5+260,829 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 13 Feb 2025 | PURCHASE | KalVista Pharmaceuticals, Inc. | 61,700 | 9.33 USD | |
| 12 Feb 2025 | PURCHASE | KalVista Pharmaceuticals, Inc. | 100,000 | 9.23 USD | first after silence |
| 22 Jan 2024 | PURCHASE | KalVista Pharmaceuticals, Inc. | 67,546 | 12.55 USD | first after silence |
| 24 Jan 2024 | PURCHASE | KalVista Pharmaceuticals, Inc. | 20,686 | 12.44 USD | |
| 23 Jan 2024 | PURCHASE | KalVista Pharmaceuticals, Inc. | 10,897 | 12.54 USD | |
| 16 Jun 2022 | PURCHASE | Tricida, Inc. | 5,951 | 9.69 USD |
2 purchases reported after at least 12 months of silence — most recent on 12 Feb 2025.